Comparison of the therapeutic effects of two vanadium complexes administered at low doses on benzo[a]pyrene-induced malignant tumors in rats

Cancer Letters

Volumn 119, Issue 2, 1997, Pages 221-225

  Evangelou, Angelos ^a,b   Karkabounas, Spiros ^a   Kalpouzos, George ^a   Malamas, Michael ^a   Liasko, Roman ^a   Stefanou, Dimitris ^a   Vlahos, Antonis T ^b   Kabanos, Themistoklis A ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Benzo a pyrene; L cysteine; Leiomyosarcomas; N (2 mercaptopropionyl) glycine; Vanadium(III) complexes; Wistar rats

Indexed keywords

BENZO[A]PYRENE; CYSTEINE; TIOPRONIN; VANADIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; LEIOMYOSARCOMA; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SURVIVAL TIME; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZO(A)PYRENE; CARCINOGENS; DRUG SCREENING ASSAYS, ANTITUMOR; LEIOMYOSARCOMA; MALE; RATS; RATS, WISTAR; SARCOMA, EXPERIMENTAL; SURVIVAL ANALYSIS; VANADIUM COMPOUNDS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0030668588     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00278-4     Document Type: Article

References (16)

1. J.H. Tomson, N.D. Chasteen, L.D. Meeker, Dietary vanadyl (IV) sulfate inhibits chemically-induced mammary carcinogenesis, Carcinogenesis, 5 (1984) 849-851.
2. A. Bishayee, R.M. Chatterjee, Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by phenobarbital, Br. J. Cancer, 71 (1995) 1214-1220.
3. A. Bishayee, R.M. Chatterjee, Inhibition of altered liver cell foci and persistent nodule growth by vanadate during diethyl-nitrosamine-induced hepatocarcinogenesis in rats, Anticancer Res., 15 (1995) 455-461.
4. P. Kopf-Maier, H. Koph, Vanadocen dichloride - another antitumor agent from the metallocene series, Z. Naturforsch, 84b (1979) 805-807.
5. T.F. Cruz, A. Morgan, W. Min, Antineoplastic effects of vanadium compounds, Proc. Annu. Meet. Am. Assoc. Cancer Res., 36 (1995) A2357.
6. C. Djorgevitz, Antitumor activity of vanadium compounds, in: H. Sigel and A. Sigel (Eds), Metal Ions in Biological Systems, Vol. 31, pp. 596-616, Marcel Dekker, New York, 1995.
7. G. Kallistratos, A. Evangelou, N. Agnantis, E. Fasske, S. Karkabounas, A. Donos, Enhancement of the antineoplastic effect of anticarcinogens on benzo[a]pyrene-treated rats, in relation to their number and biological activity, Cancer Lett., 82 (1994) 153-165.
8. T. Kabanos, A. Evangelou, A. Vlahos, Unpublished data, 1997.
9. G. Kalpouzos, Antioxidant effects on experimental chemical carcinogenesis. Thesis, Medical Faculty, University of Ioannina, Greece, 1996.
10. R. Lazzaro, G. Cros, J.H. McNeil, J.J. Serrano, Complexed vanadium for the treatment of diabetes mellitus, European Patent EP 3052 64, issued 1 March 1989.
11. G. Carpenter, Vanadate, epidermal growth factor and the stimulation of DNA synthesis, Biochem. Biophys. Res. Commun., 102 (1981) 1115-1121.
12. C. Hori, T. Oka, Vanadate enhances the stimulatory action of insulin on DNA synthesis in cultured mouse mammary glands, Biochem. Biophys. Acta, 610 (1980) 235-240.
13. B.S. Jandhyala, G.J. Horn, Minireview: physiological and pharmacological effects of vanadium, Life Sci., 33 (1983) 1325-1340.
14. K. Kustin, J.G. Macara, The new biochemistry of vanadium, Comments Inorg. Chem., 102 (1982) 1-72.
15. K. Iwai, S. Kimura, T. Ido, R. Iwata, Tumor uptake of vanadium-48, vanadyl chlorine E-6 sodium, as a tumor imaging agent, in tumor bearing mice, Nucl. Med. Biol., 17 (1980) 775-780.
16. S. Ramanadham, J.-J. Mongold, R.W. Brownsey, G.H. Cros, J.H. McNeil, Oral vanadyl sulfate in treatment of diabetes mellitus in rats, Am. J. Physiol., 257 (1989) H904-H911.